Captopril
- Product NDC
- 70518-3307
- 11-digit product format
- 705183307
- Labeler code
- 70518
- Product ID
- 70518-3307_d42662b5-0fd4-ccb7-e053-2995a90a39de
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Captopril
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA212809
- Marketing category
- ANDA
- Marketing start
- 2021-12-23
- Marketing end
- 0000-00-00
- Substance
- CAPTOPRIL
- Active strength
- 13 mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-3307-0 | 70518330700 | 28 TABLET in 1 BLISTER PACK (70518-3307-0) | 28 tablet | 2021-12-23 | 0000-00-00 | No | No | Current |